市场调查报告书
商品编码
1423621
到 2030 年数位心理治疗市场预测:按类型、解决方案、经营模式、应用、最终用户和地区进行的全球分析Digital Psychotherapeutics Market Forecasts to 2030 - Global Analysis By Type, Solution, Business Model, Application, End User and By Geography |
根据Stratistics MRC预测,2023年全球数位心理治疗市场规模将达到10.6亿美元,预计在预测期内将以27.6%的复合年增长率成长,到2030年达到102.5亿美元。
数位心理治疗是指利用行动应用程式和线上平台等数位技术为心理健康问题提供治疗性介入。这些解决方案通常结合认知行为疗法 (CBT) 和正念等实证治疗技术,并且可以为寻求心理健康护理的个人提供远端支援。
根据澳洲统计局预测,2022年,21.5%的人会出现为期12个月的精神障碍,其中以焦虑症最为常见(16-85岁族群为17.2%)。此外,世界上八分之一的人患有精神障碍。
精神疾病呈上升趋势
社会压力的增加、经济的不确定性以及数位时代的影响导致了心理健康障碍的激增。此外,高压职场环境和经常接触的现代生活方式可能会加剧心理健康挑战,并导致心理健康障碍的盛行率显着增加。数位心理治疗利用科技提供可扩展和个人化的介入措施,使心理健康支援更加广泛。个人和医疗保健提供者越来越多地转向数位解决方案,以应对与精神健康障碍相关的日益严峻的挑战,而需求的激增正在推动市场扩张。
资料隐私和安全问题
心理健康资料的敏感性使其成为网路威胁的有吸引力的目标,并可能导致未授权存取和滥用。由于担心违反保密性,患者可能会犹豫是否采用数位心理治疗解决方案。建立强大的加密和身份验证机制对于向用户灌输信任至关重要,但资料外洩的威胁仍然是一项重大挑战,阻碍了数位心理治疗的普及。
用户友好的平台和应用程式的兴起
使用者友善的平台和应用程式利用以使用者为中心的设计和先进技术来提高心理健康干预措施的可及性和参与度。这些新兴平台专注于便利性和个人化体验,正在迎合更广泛的受众,并推动数位心理治疗的广泛采用。随着对无障碍心理健康解决方案的需求持续增长,市场有望透过这些用户友好的应用程式扩大。
与传统治疗方法的竞争
儘管数位解决方案具有便利性和可访问性的优点,但一些个人和医疗保健提供者仍然更喜欢或依赖传统的治疗方法。对数位心理治疗的有效性和可靠性的怀疑可能会阻碍其被接受。对众所周知的方法的依赖和传统治疗方法的个人化性质有助于形成竞争形势。因此,传统治疗方法的既定声誉和长期接受度将是市场吸引力的关键挑战。
COVID-19 的影响
COVID-19 大流行显着加速了数位心理治疗的采用,在全球心理健康挑战日益恶化的情况下,需求激增。人们对心理健康意识的不断提高,加上关门和社交距离,促使人们转向远端和数位心理健康解决方案。远端医疗平台、心理健康应用程式和虚拟支援工具推动了数位心理治疗市场的发展,并获得了很高的接受度。
穿戴式装置市场预计将在预测期内成为最大的市场
预计穿戴式装置产业将出现利润丰厚的成长。透过将科技融入心理健康干预措施,穿戴式装置在数位心理治疗中发挥关键作用。这些设备通常佩戴在身上,收集即时生理资料并实现个人化、资料驱动的治疗。透过监测生命征象、睡眠模式和活动量并向治疗师提供客观的见解来提高治疗效果。这种连续的资料流有助于更有针对性的干预,并能够及时调整治疗计划。
焦虑症产业预计在预测期内复合年增长率最高
焦虑症产业预计在预测期内将出现最高的复合年增长率。数位心理治疗透过提供可访问的、个人化的和可扩展的干预措施,为焦虑症提供了一个有前途的解决方案。这些平台通常结合实证治疗技术、认知行为治疗模组和正念练习来解决焦虑症状。方便灵活的心理保健方法正在推动这一领域的需求。
由于人们对心理健康问题的认识不断提高、智慧型手机普及不断提高以及技术进步,亚太地区预计将在预测期内占据最大的市场占有率。 COVID-19 大流行对心理健康的影响提高了该地区对远端医疗的接受度。中国以其强大的技术基础设施而闻名,远端医疗、行动医疗应用和穿戴式装置在中国取得了巨大进步。因此,远端医疗和数位医疗技术的强劲进步可能会继续推动该地区的成长。
由于有利的赎回情况,预计北美在预测期内将出现最高的复合年增长率。随着美国的数位心理治疗产业预计将持续发展。焦虑、忧郁症和创伤后压力症候群(PTSD)是美国常见的精神疾病。北美是塑造数位心理治疗未来、推动创新和可近性的关键参与者。该地区完善的医疗基础设施,加上数位干预措施的接受度不断提高,正在推动市场扩张。
According to Stratistics MRC, the Global Digital Psychotherapeutics Market is accounted for $1.06 billion in 2023 and is expected to reach $10.25 billion by 2030 growing at a CAGR of 27.6% during the forecast period. Digital psychotherapeutics refers to the use of digital technologies, such as mobile apps and online platforms, to deliver therapeutic interventions for mental health issues. These solutions often incorporate evidence-based therapeutic techniques, such cognitive-behavioural therapy (CBT) or mindfulness, and can provide remote and accessible support to individuals seeking mental health care.
According to Australian Bureau of Statistics, in 2022, 21.5% of people had a 12-month mental disorder, with anxiety being the most common group (17.2% of people aged 16-85 years). In addition, 1 out of every 8 individuals in this world suffers from a psychological disorder.
Increasing mental health disorders
The heightened societal stressors, economic uncertainties and the impact of the digital age surge in mental health disorders. Also, modern lifestyles, with high-pressure work environments and constant connectivity, may exacerbate mental health challenges, leading to a notable increase in the prevalence of mental health disorders. Digital psychotherapeutics leverage technology to offer scalable, personalized interventions, making mental health support more widely available. This surge in demand is driving the expansion of the market, as individuals and healthcare providers increasingly turn to digital solutions to address the escalating challenges associated with mental health disorders.
Data privacy & security concerns
The sensitive nature of mental health data makes it a prime target for cyber threats, potentially leading to unauthorized access and misuse. Patients may hesitate to adopt digital psychotherapeutic solutions due to fears of breaches in confidentiality. Building robust encryption and authentication mechanisms is crucial to instill trust among users, but the persistent threat of data breaches remains a key challenge, impeding the widespread adoption of digital psychotherapeutics.
Rising user-friendly platforms & apps
The user-friendly platforms and apps leverage user-centric design and advanced technologies to enhance accessibility and engagement in mental health interventions. With a focus on convenience and personalized experiences, these rising platforms cater to a broader audience, fostering increased adoption of digital psychotherapeutics. As the demand for accessible mental health solutions continues to rise, the market is poised for expansion through these user-friendly applications.
Competition with traditional therapies
While the convenience and accessibility of digital solutions offer advantages, some individuals and healthcare providers may still prefer or rely on traditional therapeutic approaches. Skepticism around the efficacy and reliability of digital psychotherapeutics may impede their acceptance. Trust in well-known methods and the personalized nature of traditional therapy contributes to the competitive landscape. Therefore, the established reputation and long-standing acceptance of traditional therapeutic methods pose a significant challenge for the market to gain traction.
Covid-19 Impact
The covid-19 pandemic has significantly accelerated the adoption of Digital Psychotherapeutics, witnessing a surge in demand as mental health challenges escalated globally. The increased awareness of mental well-being, coupled with lockdowns and social distancing measures, prompted a shift towards remote and digital mental health solutions. Teletherapy platforms, mental health apps, and virtual support tools experienced heightened acceptance, driving the digital psychotherapeutics market.
The wearable devices segment is expected to be the largest during the forecast period
The wearable devices segment is estimated to have a lucrative growth. Wearable devices play a pivotal role in digital psychotherapeutics by integrating technology into mental health interventions. These devices, often worn on the body, collect real-time physiological data, enabling personalized and data-driven therapy. They enhance therapy effectiveness by monitoring vital signs, sleep patterns, and activity levels, providing therapists with objective insights. This continuous data stream fosters more targeted interventions and allows for timely adjustments to treatment plans.
The anxiety disorders segment is expected to have the highest CAGR during the forecast period
The anxiety disorders segment is anticipated to witness the highest CAGR growth during the forecast period. Digital psychotherapeutics offer promising solutions for anxiety disorders by providing accessible, personalized, and scalable interventions. These platforms often incorporate evidence-based therapeutic techniques, cognitive-behavioural therapy modules, and mindfulness practices to address anxiety symptoms. It's convenient and flexible approach to mental health care fuels the segment demand.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the increasing awareness of mental health issues, rising smartphone penetration, and advancements in technology. The covid-19 pandemic's impact on mental health raised the acceptance of telehealth in the region. China is well-known for its strong technology infrastructure and telemedicine, mobile health applications, & wearable gadgets have seen tremendous improvements in the country. Thereby, robust advancements in telemedicine and digital health technology is likely to continue pushing growth in the region.
North America is projected to have the highest CAGR over the forecast period owing to the favourable reimbursement scenarios. The digital psychotherapeutics industry in the United States is expected to progress as the country's mental health awareness grows. Anxiety, depression, and post-traumatic stress disorder (PTSD) are common mental health illnesses in the United States. North America is a key player in shaping the future of digital psychotherapeutics, fostering innovation and accessibility. The region's well-established healthcare infrastructure, coupled with a growing acceptance of digital interventions, fosters market expansion.
Key players in the market
Some of the key players profiled in the Digital Psychotherapeutics Market include Pear Therapeutics, Akili Interactive, Happify Health, Headspace, Ginger, Lantern, Limbix, Big Health, Mindstrong Health, NeuroFlow, SilverCloud Health, Talkspace, Woebot Health, Kaia Health, Novartis, Spring Health, Koa Health and Meru Health.
In November 2023, Spring Health, the most comprehensive global mental health solution for employers and health plans, announced the launch of a new dedicated teen experience. Spring Health for teens is the latest innovation in the Family Care suite of services, which offers mental health care and support for all ages.
In November 2018, Sandoz, a division of Novartis partnered with Pear Therapeutics and launched reSET - a substance use disorder treatment that was the first software-only therapeutic cleared by the FDA. reSET is a 12-week digital cognitive behavioral therapy program accessed through an app and designed to accompany outpatient care delivered by a physician.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.